Project Number PTC REG-20-653269 Agency/Funding Organization Alzheimer's Association Funding Year 2020 View Full Project Details for SEMA4D Blockade Safety and Brain Metabolic Activity in Alzheimer’s Disease Research Categorization Primary Disease / Condition Alzheimer's Disease CADRO Category C. Translational Research and Clinical Interventions 7. Early-stage Clinical Drug Development (Phase I and II Clinical Trials) f. Inflammation Researcher and Organization Principal Investigator Zauderer, Maurice Principal Investigator First Name Maurice Principal Investigator Last Name Zauderer Awardee Organization Vaccinex, Inc. Awardee State New York, N.Y. Contact PI Country United States Project Detail Funding Opportunity Announcement PA 2020: PTC RFA FY Overall Cost $750,000 Funding Organization Agency/Funding Organization Alzheimer's Association Funding Organization Country United States Program Official Murtishaw, Andrew asmurtishaw@alz.org
